US HB5391 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on September 12 2023 - 25% progression, died in committee
Action: 2023-09-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Protecting Patient Access to Cancer and Complex Therapies Act

Sponsors


History

DateChamberAction
2023-09-15HouseReferred to the Subcommittee on Health.
2023-09-12HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-09-12HouseIntroduced in House

Same As/Similar To

SB2764 (Related) 2023-09-12 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback